{"name":"ES Therapeutics Australia Pty Ltd","slug":"es-therapeutics-australia-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQSU1nZ0VqM3RfRGppZVpmaW9IaWEtSXFzMDVLc3QybFZPQnMyb2szcm0xeDB2UGNJeVQ1dUpEMlU4Sy0tamtsQ0lJV0Z4VGc4WFdkcjJTN0VJa1RhRXB6YWNNempmZURoRE95Y05ocktOeEFOeHdtcHkwT3d5NnYwTmNDNjNDVUFERkRNTk9BOVp6cU1SSmk0YUNKQQ?oc=5","date":"2026-03-24","type":"trial","source":"openPR.com","summary":"Epilepsy Clinical Trial Pipeline Appears Robust With 75+ Key - openPR.com","headline":"Epilepsy Clinical Trial Pipeline Appears Robust With 75+ Key","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-23","type":"pipeline","source":"prnewswire.com","summary":"Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Sur","headline":"Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophth","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-18","type":"pipeline","source":"The Australian","summary":"2025 Wrapped: Recce Pharmaceuticals - The Australian","headline":"2025 Wrapped: Recce Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQQXdqel9HRDhiTHYySjVlWXhuY0lCdGRwaTd2X3FvSkVnbHF1aWpfT1doQWtRN214d3BvWHRrVTlvRkhIWWFicnA3Z2VLb2lmTkFqekJMV3VWUUloOWdFeU95Z2dXSm12dEQwRXlmTmNFSms1RE5US2lkLXNubUhWMGsxeldwU0w0UXp4b1RXeExHVDFwMDFUblRfMVZRdGJBNHJwN1h0clpCQmZ2TEJMT3BDYUZYMThCakEtV2xnNEY4eGFs?oc=5","date":"2025-12-01","type":"deal","source":"BioSpectrum Asia","summary":"India's SAI Parenterals acquires Australia-based Noumed Pharma for Rs 125 Cr - BioSpectrum Asia","headline":"India's SAI Parenterals acquires Australia-based Noumed Pharma for Rs 125 Cr","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-28","type":"deal","source":"simplywall.st","summary":"Insider Buys Additional AU$200k In PYC Therapeutics Stock - simplywall.st","headline":"Insider Buys Additional AU$200k In PYC Therapeutics Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQa1dmdTJzS2dhdXAxRmNEcDFVRENVdGEzSloxRUcxQmJaX05SaUh0YWRjQjRybDNONko1T3hWRXBpR1dONUYxZHlCY3l5S0tKcmI5enhTcHlqQTdHZGk4N0R5YVVqak9HUHlsMy14TGkySElYUXhLcS1lekhMRmdSbmx6SWx6YXY4cFV2akhMckM2bHJkMVVIcW9CTVNHZkZsdzlOdmJTeFY?oc=5","date":"2025-11-07","type":"pipeline","source":"UWA","summary":"UWA research recognised in Innovator of the Year Awards - UWA","headline":"UWA research recognised in Innovator of the Year Awards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQWG5ybDdZZGxVVGxCYnc5ZFBjRFRNM2ZCcktQZ2xmRGt3OVRxaE1JNlJINFZpbXdwYjlQcmhMS1ZNSkpsY2k5d3d6am8zcGtXZlFKeUtpQVktekVTOVZEQnY1d2RZeHVLaExiQkNaS2pXY3pzSzkzZDNITzV6TjhMckNVTzhEMmY4Z0tYazA4dnJoRHo3dF9heWVyTQ?oc=5","date":"2025-10-07","type":"pipeline","source":"Yahoo Finance","summary":"Analysts Expect Breakeven For Botanix Pharmaceuticals Limited (ASX:BOT) Before Long - Yahoo Finance","headline":"Analysts Expect Breakeven For Botanix Pharmaceuticals Limited (ASX:BOT) Before Long","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxObzdrV3paMTdLbThmc2pWVUUzZlZMckVvVW9xYmJtekVPb2VfVG5vZmVTSTZHYzJaY2NkZTg4Q1o3V0ZwWktXNDFHYWxGX0hyUl9JdDZXQ3Z4dHJhUExMM1ZRa2NWaGx1cUtzNnpyb3R4V0ZfbklqMVF6Tlg3MEhES0Mxb0toMk4wVHZTQm5OWDlObkNFN0E?oc=5","date":"2025-07-24","type":"pipeline","source":"abc.net.au","summary":"Australia's most common ADHD drug has had a spike in adverse event reports - abc.net.au","headline":"Australia's most common ADHD drug has had a spike in adverse event reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxNelhGRWdNOUpyWkFNSHZzMml5MHFvYnpHMmVhN0RjRmZ6UW5WR0hMeTM2SG91enFaNUk0ODRmekxuQWxjMHo1eHRpRlR4ZXZLNFpIOEkzQTRMMnNDaWNiUXQtMFFON2VFSWRJUUp4MXUySklNUThyRXlVSlYyOEVyR1hENnBUT1gtQmtGTDE1clFDNmhYWWNGTG1VSVFWUXl1cnBSNW9Rdkdpa0FFU3RsWlZXVVVJc2VoOFZRZ1lPekVyTUtLZGNGM0cxMlZaQkstMFRzbkx5YVNHdzJmbm1qOEdKWFhQQ3dDNWFCZXJYS2JOUjhCM0Z2OVV0Z3NocUpVRTJSY3BKSzVoaVowOWpkZzROSXV3dkFVRm9EVVlxNmNPVmM?oc=5","date":"2025-04-08","type":"pipeline","source":"GlobeNewswire","summary":"Developmental and Epileptic Encephalopathies Market to - GlobeNewswire","headline":"Developmental and Epileptic Encephalopathies Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOWUhMX2hkSncyZ1J3Q0JwQ1FwQ2pHZWhVOXdQSXl0V3hqMW5PZzIzWWsxX2F6bmlKTHVGVGQ2UmNLMWN6Wlg4T1ZnaDlqZHZIUW4tVzN6blRiemIyX3dyMkRRdzlJUzhPUnBvamVXUXZ3dHpxbGlMd1AxaEJvTWFxbnlrRzZleXZpYTk0aWZyM1g?oc=5","date":"2024-02-14","type":"regulatory","source":"Frontiers","summary":"Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review - Frontiers","headline":"Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A System","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE0yeWxPcGR0dHhDcDJJNlhBZmRFMXFsaGhvTmJjUGMtSG5tS0l1dzl2MFNkZW5SZnBLekFvQUhaczhWNmF5Ymk5SGRHWUMzWktOWlh6a3dpUGlNSndYd3dKVw?oc=5","date":"2023-10-27","type":"deal","source":"复宏汉霖","summary":"Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India - 复宏汉霖","headline":"Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India - 复宏汉霖","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE96eEs2WEFMeU9iNFJMZWJCZEdvWkVMOFFSYWpweW9sZjNuYjFiNzBaS3A0RkhhN21DYzhrdS1CT21fY0xpZW1fd3hIYTRsSkxQby1XOWFnQnUzQnppeVV4ck9pWVF6b2lTdlE?oc=5","date":"2022-10-31","type":"pipeline","source":"Wiley Online Library","summary":"Does long‐term phenytoin have a place in Dravet syndrome? - Wiley Online Library","headline":"Does long‐term phenytoin have a place in Dravet syndrome?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}